Capricorn Fund Managers Ltd purchased a new position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 75,602 shares of the company’s stock, valued at approximately $6,926,000. HealthEquity accounts for 1.7% of Capricorn Fund Managers Ltd’s holdings, making the stock its 20th biggest position. Capricorn Fund Managers Ltd owned approximately 0.09% of HealthEquity at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Sivia Capital Partners LLC purchased a new stake in HealthEquity in the second quarter worth $306,000. Prudential Financial Inc. boosted its stake in shares of HealthEquity by 39.7% during the second quarter. Prudential Financial Inc. now owns 14,155 shares of the company’s stock valued at $1,437,000 after purchasing an additional 4,022 shares during the period. Hsbc Holdings PLC grew its holdings in shares of HealthEquity by 144.8% in the second quarter. Hsbc Holdings PLC now owns 7,561 shares of the company’s stock worth $793,000 after purchasing an additional 4,472 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new position in shares of HealthEquity in the second quarter worth about $4,747,000. Finally, CW Advisors LLC increased its stake in HealthEquity by 56.0% in the 2nd quarter. CW Advisors LLC now owns 5,107 shares of the company’s stock worth $535,000 after buying an additional 1,834 shares during the period. 99.55% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the stock. Barclays lowered their price objective on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday, February 18th. BMO Capital Markets reaffirmed a “market perform” rating on shares of HealthEquity in a research note on Wednesday, March 18th. Jefferies Financial Group set a $108.00 price target on HealthEquity in a report on Thursday, February 19th. UBS Group set a $110.00 price objective on HealthEquity in a research note on Tuesday, February 17th. Finally, Raymond James Financial set a $100.00 price objective on HealthEquity in a report on Tuesday, February 17th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $110.36.
HealthEquity Price Performance
NASDAQ HQY opened at $84.67 on Monday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.27 and a current ratio of 3.27. The firm’s 50 day moving average price is $79.90 and its 200-day moving average price is $89.35. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $116.65. The company has a market cap of $7.15 billion, a PE ratio of 34.42, a P/E/G ratio of 1.54 and a beta of 0.26.
HealthEquity (NASDAQ:HQY – Get Free Report) last issued its quarterly earnings data on Tuesday, March 17th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. The company had revenue of $334.59 million during the quarter, compared to the consensus estimate of $332.48 million. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The business’s revenue for the quarter was up 7.3% compared to the same quarter last year. Sell-side analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Read More
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
